New Swiss biotech fund
Newly formed HBM BioVentures plans to raise a CHF750m ($420m) fund for investment in private as well as public pharmaceutical and biotech companies.
Newly formed HBM BioVentures plans to raise a CHF750m ($420m) fund for investment in private as well as public pharmaceutical and biotech companies.
Copyright PEI Media
Not for publication, email or dissemination